Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Post-Transplant Cytomegalovirus (CMV) Infection/Disease. Show all posts
Showing posts with label Post-Transplant Cytomegalovirus (CMV) Infection/Disease. Show all posts
Wednesday, December 15, 2021

FDA Approves Livtencity (maribavir) for Post-Transplant Cytomegalovirus (CMV) Infection/Disease

›
Takeda Pharmaceutical Company Limited   (“Takeda”)   announced   the U.S. Food and Drug Administration (FDA)   approval of    Livtencity ™ (...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.